Europe Cannabis Testing Market

Market Introduction

Medicinal Cannabis is now legal in most of the regions across the world. It is crucial to test the cannabis products used for medicinal purposes to avoid side effects. Cannabis testing is used in various applications that include determining the concentration of cannabis in various analytical samples such as pharmaceutical drugs, and detection of contaminants such as bacteria and fungi. Further, the Cannabis testing is also performed for the determination of trace metals, such as arsenic and cadmium that can adversely impact human health if remained unchecked. These tests are performed with the help of various analytical techniques such as chromatography, spectrometry, ELISA, and polymerase chain reaction (PCR).

Market Overview and Dynamics

The Europe cannabis testing market is expected to reach US$ 770.30 million by 2027 from US$ 431.58 million in 2019. The market is anticipated to grow with a CAGR of 7.7% from 2020 to 2027.  The growth of the market in the region is attributed to the factors such as increasing government funding and focus for cannabis use and increasing demand for research activities to improve the quality of cannabis. However, the cannabis used as a street drug and trouble with CBD oil are the factors negatively impacting the growth of the market in the coming years.

Key Market Segments

In terms of product, the chromatography instruments segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. In terms of service, the potency testing segment held the largest share of the market in 2019 and is estimated to register the highest share in the market during the forecast period. In terms of end user, the testing laboratories segment held the largest share of the market in 2019 and is estimated to register the highest  CAGR in the market during the forecast period.

Major Sources and Companies Listed

European Union, National Center for Biotechnology Information, and International Cannabis and Cannabinoids Institute are among the major secondary sources for the Europe cannabis testing market included in the report.

Reasons to buy the report

• To understand the Europe cannabis testing market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe cannabis testing market
• Efficiently plan M&A and partnership deals in the Europe cannabis testing market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Europe cannabis testing market
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Europe Cannabis Testing Market Segmentation

By Product

• Chromatography Instruments
  • Liquid Chromatography
  • Gas Chromatography
• Spectroscopy
  • Mass Spectrometry
  • Atomic Spectrometry
• Consumables
  • Standard and CRMs
• Software

By Service

• Potency Testing
• Terpene Profiling
• Pesticide Screening
• Residual Solvent Screening
• Heavy Metal Testing
• Microbial Analysis
• Genetic Testing

By End User

• Testing Laboratories
• Drug Manufacturers
• Research Institutes

Company Profiles

• Agilent Technologies, Inc.
• Perkin Elmer, Inc.
• Shimadzu Corporation
• Sciex (Danaher)
• Merck KGaA
• Restek Corporation
• Waters
• Cannasafe Analytics
• Accelerated Technology Laboratories, Inc.
• Digipath Inc.

Europe Cannabis Testing Market Strategic Insights

Europe Cannabis Testing Market Report Highlights

Europe Cannabis Testing Market Country and Regional Insights